In line with ACR recommendations, allopurinol is strongly suggested as a primary-line urate-decreasing medication. Genetic tests is usually recommended (for any variant identified as HLA B*5801) before commencing allopurinol as the carriers of this gene are at an increased risk of a serious allergic response.Gout was at the time regarded as a wealt